Picture of CONCORD DRUGS logo

538965 CONCORD DRUGS Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual cashflow statement for CONCORD DRUGS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line42.922.512.56.296.91
Depreciation
Non-Cash Items12.41416.318.620.1
Other Non-Cash Items
Changes in Working Capital-52.8-46.4-28.4-32.5-4.13
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities16.27.7416.67.9237.2
Capital Expenditures-36.7-0-8.57-10.2-23.3
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0810.123-14.10.0930.145
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-36.70.122-22.7-10.1-23.2
Financing Cash Flow Items-13.3-17.8-10.7-8.58-20.3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities20.716.86.242.83-14.3
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.23424.70.2150.67-0.245